Bill > H0339

This bill adds a new section to Idaho's existing pharmacy laws to establish provisions regarding certain drug product substitutions. The key provisions of the bill are: 1. It allows a licensed prescriber to authorize a pharmacist to substitute a drug with another drug in the same therapeutic class, even if the substitute drug is not a therapeutic equivalent, as long as the substitute drug would have a substantially equivalent therapeutic effect. 2. The bill sets forth several conditions that must be met for this type of drug product substitution, including that the prescriber has indicated substitution is permissible, the substitution is intended to ensure formulary compliance or lower costs for the patient, the patient opts in to the substitution, and the pharmacist informs the patient of the differences and that they can refuse the substitution. 3. The bill excludes biological products and narrow therapeutic index drugs from these new drug product substitution provisions. 4. The bill defines key terms used, including "drug product substitution," "narrow therapeutic index drug," "therapeutic class," and "therapeutic equivalent drug."

Health and Social Services

Health and Welfare Committee (House)

https://legislature.idaho.gov/sessioninfo/2018/legislation/H0339/